Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wilfried Auer
Observed names:
W Auer,
W. Auer
Institution:
Baxter (Austria)
Observed institutions:
Sanquin,
Baxter (Austria),
Hôpital Lariboisière,
München Klinik,
Hôpital Raymond-Poincaré,
Austrian Red Cross,
Ludwig-Maximilians-Universität München
show all 7
OpenAlex ID:
A5113785708
Hypertension and hyperlipidaemia: garlic helps in mild cases.
1990
·
W Auer
, A Eiber
, et al.
·
PubMed
·
125
Factor Xa and Prothrombin: Mechanism of Action of FEIBA
1999
·
Peter L. Turecek
, Katalin Varadi
, et al.
·
Vox Sanguinis
·
67
PDF
In Vivo Characterization of Recombinant von Willebrand Factor in Dogs With von Willebrand Disease
1997
·
Peter L. Turecek
, Herbert Gritsch
, et al.
·
Blood
·
51
A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state‐of‐the‐art process
2006
·
W. Teschner
, H. A. Butterweck
, et al.
·
Vox Sanguinis
·
48
Effects of α1‐acid glycoprotein in different rodent models of shock
1998
·
E‐M Muchitsch
, W Auer
, et al.
·
Fundamental and Clinical Pharmacology
·
43
Assessment of Bleeding for the Evaluation of Therapeutic Preparations in Small Animal Models of Antibody-Induced Hemophilia and von Willebrand Disease
1997
·
P L Turecek
, H Gritsch
, et al.
·
Thrombosis and Haemostasis
·
43
Phenotypic Expression of Murine Hemophilia
1999
·
E.-M. Muchitsch
, P. L. Turecek
, et al.
·
Thrombosis and Haemostasis
·
39
Evidence for Extracellular Processing of Pro-von Willebrand Factor After Infusion in Animals With and Without Severe von Willebrand Disease
1999
·
P.L. Turecek
, L. Pichler
, et al.
·
Blood
·
25
Recombinant von Willebrand Factor: Preclinical Development
2001
·
Barbara Plaimauer
, Uwe Schlokat
, et al.
·
Seminars in Thrombosis and Hemostasis
·
20
Recombinant von Willebrand Factor-Insight into Structure and Function through Infusion Studies in Animals with Severe von Willebrand Disease
2002
·
Hans Peter Schwarz
, Uwe Schlokat
, et al.
·
Seminars in Thrombosis and Hemostasis
·
17
Preclinical Testing of Human Recombinant von Willebrand Factor: ADAMTS13 Cleavage Capacity in Animals as Criterion for Species Suitability
2010
·
Eva-Maria Muchitsch
, Barbara Dietrich
, et al.
·
Seminars in Thrombosis and Hemostasis
·
13
Impact of Factor IXa Content On Function, Safety and Efficacy of Recombinant Factor IX Products.
2012
·
Wilfried Auer
, Hanspeter Rottensteiner
, et al.
·
Blood
·
1
Studies on the effect of human lys-plasminogen in a rat model of global cerebral ischemia.
1997
·
W Auer
, E M Muchitsch
, et al.
·
PubMed
·
1
Rekombinanter von Willebrand-Faktor: Präklinik
1997
·
P. L. Turecek
, J. Siekmann
, et al.
·
Springer eBooks
·
1
Preclinical Safety of Baxter's Recombinant Factor VIIa
2010
·
Barbara Dietrich
, Susan Kubik
, et al.
·
Blood
Preclinical Safety of Baxter's Recombinant Factor IX
2010
·
Barbara Dietrich
, Susan Kubik
, et al.
·
Blood
Preclinical Comparison of Human Alpha1-proteinase Inhibitor Fraction Iv-1 With A1pi From Fraction Iv-1+4
2006
·
Eva M. Muchitsch
, Susan M. Kubik
, et al.
·
CHEST Journal
Lysine Truncation of Alpha1-proteinase Inhibitor Upon Diffusion From the Vasculature Into Broncheoalveolar Lavage
2006
·
Eva M. Muchitsch
, Alfred Weber
, et al.
·
CHEST Journal
Preclinical characterization of a new liquid “immune globulin intravenous (human), 10% triple virally reduced solution” (IGIV, 10%TVR)
2004
·
W. Teschner
, W. Auer
, et al.
·
Journal of Allergy and Clinical Immunology
PDF
Experimenteller Vergleich von Behandlungsalternativen: Prothrombinase, FEIBA, Hochdosis-Faktor VIII und aktivierter Faktor VII in einem Kaninchen-Inhibitormodell
1998
·
P. L. Turecek
, H. Gritsch
, et al.
·
Springer eBooks
Show more works
View as search
Works count:
20
Citation count:
494
H-index:
11
I10-index:
11
Year
Topic
Type